These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34753031)

  • 21. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
    Wald DS; Bestwick JP
    Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.
    Campbell-Salome G; Jones LK; Masnick MF; Walton NA; Ahmed CD; Buchanan AH; Brangan A; Esplin ED; Kann DG; Ladd IG; Kelly MA; Kindt I; Kirchner HL; McGowan MP; McMinn MN; Morales A; Myers KD; Oetjens MT; Rahm AK; Schmidlen TJ; Sheldon A; Simmons E; Snir M; Strande NT; Walters NL; Wilemon K; Williams MS; Gidding SS; Sturm AC
    Circ Genom Precis Med; 2021 Feb; 14(1):e003120. PubMed ID: 33480803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Digiphysical cascade screening model to diagnose familial hypercholesterolemia in relatives to an index case].
    Littmann K; Kindborg G; Nathanson D; Brinck J
    Lakartidningen; 2022 Apr; 119():. PubMed ID: 35471725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia.
    Lázaro P; Pérez de Isla L; Watts GF; Alonso R; Norman R; Muñiz O; Fuentes F; Mata N; López-Miranda J; González-Juanatey JR; Díaz-Díaz JL; Blasco AJ; Mata P
    J Clin Lipidol; 2017; 11(1):260-271. PubMed ID: 28391894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia.
    Silva PRS; Jannes CE; Oliveira TGM; Gómez LMG; Krieger JE; Santos RD; Pereira AC
    Arq Bras Cardiol; 2018 Oct; 111(4):578-584. PubMed ID: 30156605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
    McKay AJ; Hogan H; Humphries SE; Marks D; Ray KK; Miners A
    Atherosclerosis; 2018 Aug; 275():434-443. PubMed ID: 29937236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient acceptance of genetic testing for familial hypercholesterolemia in the CASCADE FH Registry.
    Gidding SS; Sheldon A; Neben CL; Williams HE; Law S; Zhou AY; Wilemon K; Ahmed CD; Kindt I
    J Clin Lipidol; 2020; 14(2):218-223.e2. PubMed ID: 32143996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cascade screening for familial hypercholesterolemia should be organized at a national level.
    Leren TP; Bogsrud MP
    Curr Opin Lipidol; 2022 Aug; 33(4):231-236. PubMed ID: 35942821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication.
    Campbell-Salome G; Walters NL; Ladd IG; Sheldon A; Ahmed CD; Brangan A; McMinn MN; Rahm AK; Schwartz MLB; Tricou E; Fisher CL; Sturm AC
    Transl Behav Med; 2022 Jul; 12(7):800-809. PubMed ID: 35429393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial of genetic testing and cascade screening in familial hypercholesterolemia.
    Ajufo E; deGoma EM; Raper A; Yu KD; Cuchel M; Rader DJ
    Genet Med; 2021 Sep; 23(9):1697-1704. PubMed ID: 34040191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil.
    Souto AC; Miname MH; Fukushima J; Jannes CE; Krieger JE; Hagger M; Pereira AC; Santos RD
    Atherosclerosis; 2018 Oct; 277():464-469. PubMed ID: 30270086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autosomal recessive hypercholesterolemia: Case report.
    Petrulioniene Z; Gargalskaite U; Mikstiene V; Norvilas R; Skiauteryte E; Utkus A
    J Clin Lipidol; 2019; 13(6):887-893. PubMed ID: 31734096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
    Ademi Z; Norman R; Pang J; Liew D; Zoungas S; Sijbrands E; Ference BA; Wiegman A; Watts GF
    Atherosclerosis; 2020 Jul; 304():1-8. PubMed ID: 32526542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cascade genetic testing of familial hypercholesterolemia A new opportunity for prevention].
    Butty A; Von Känel T; Gallino A; Beer JH; Nanchen D
    Rev Med Suisse; 2022 Mar; 18(772):438-443. PubMed ID: 35266344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.
    Wald DS; Wald NJ
    J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Chen CX; Hay JW
    Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L; Defesche J; Roeters van Lennep J
    Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.